ANI Pharmaceuticals Inc (NASDAQ:ANIP)

58.04
Delayed Data
As of Apr 24
 -0.68 / -1.16%
Today’s Change
42.23
Today|||52-Week Range
74.70
-9.95%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
First Analysis Securities Corp
Director
Sale3/09/201836,561$63.01$2.3M-7.70%
First Analysis Securities Corp
Director
Sale4/18/201833,200$62.09$2.1M-5.83%
Przybyl Arthur S
President & Chief Executive Officer
Sale3/13/201823,475$61.52$1.4M-7.08%
First Analysis Securities Corp
Director
Sale3/08/201815,391$63.08$970.9K-7.80%
Argentum Group /ny/
Director
Sale3/13/201814,000$61.81$865.3K-7.08%
First Analysis Securities Corp
Director
Sale3/12/201812,269$63.03$773.3K-7.51%
Schrepfer Robert Waldo
Sale3/01/201811,954$62.25$744.1K-4.88%
Przybyl Arthur S
President & Chief Executive Officer
Sale3/01/201811,326$60.59$686.2K-4.88%
Schrepfer Robert Waldo
Sale3/01/201810,800$61.64$665.7K-4.88%
Przybyl Arthur S
President & Chief Executive Officer
Sale3/14/201810,000$62.03$620.3K-6.45%
Page of 5